Assessing the potential role of next generation tyrosine kinase inhibitors in the treatment of cancers with acquired kinase domain mutations

Journal article

Peer reviewed

A Thirumal Raj, Shankargouda Patil, R Ranadheer and R Chandini

Oral oncology, Vol.73, pp.172-172

10/2017

PMID: 28923250

Abstract

Animals

Antineoplastic Agents - therapeutic use

Aza Compounds - therapeutic use

Disease Progression

Drug Resistance, Neoplasm - genetics

Humans

Mutation

Neoplasms - drug therapy

Neoplasms - genetics

Neoplasms - pathology

Protein Kinase Inhibitors - therapeutic use

Protein-Tyrosine Kinases - antagonists & inhibitors

1 Record Views

Title: Assessing the potential role of next generation tyrosine kinase inhibitors in the treatment of cancers with acquired kinase domain mutations
Creators - without role: A Thirumal Raj - SRI
Shankargouda Patil - Jazan University
R Ranadheer - M S Ramaiah University of Applied Sciences
R Chandini - Private Dentist Chennai, India. Electronic address: chandinirajkumar@gmail.com.
Publication Details: Oral oncology, Vol.73, pp.172-172
Identifiers: 9917507908331
Academic Unit: Jazan University
Language: English
Resource Type: Journal article